Your browser doesn't support javascript.
loading
Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.
Litwinska, Ewelina; Litwinska, Magdalena; Oszukowski, Przemyslaw; Szaflik, Krzysztof; Kaczmarek, Piotr.
Afiliação
  • Litwinska E; Perinatology and Gynecology Department, Polish Mother's Memorial Hospital Research Institute, Lódz, Poland.
  • Litwinska M; Department of Gynecology, Fertility and Fetal Therapy, Polish Mother's Memorial Hospital Research Institute, Lódz, Poland.
  • Oszukowski P; Perinatology and Gynecology Department, Polish Mother's Memorial Hospital Research Institute, Lódz, Poland.
  • Szaflik K; Department of Gynecology, Fertility and Fetal Therapy, Polish Mother's Memorial Hospital Research Institute, Lódz, Poland.
  • Kaczmarek P; Department of Operative Gynecology and Oncological Gynecology, Polish Mother's Memorial Hospital Research Institute, Lódz, Poland.
Adv Clin Exp Med ; 26(3): 439-448, 2017.
Article em En | MEDLINE | ID: mdl-28791818
BACKGROUND: Pre-eclampsia is a systemic disease connected with high maternal and fetal morbidity and mortality. Despite significant progress achieved in perinatal medicine, pre-eclampsia is still one of the most significant current problems in obstetrics. OBJECTIVES: The aim of the study was to establish diagnostic algorithms for early and late pre-eclampsia (PE) and intrauterine growth restriction (IUGR). MATERIAL AND METHODS: A total of 320 pregnant women between 11 + 0 and 13 + 6 weeks of gestation were recruited for a case-control study. The study group consisted of 22 patients with early PE, 29 patients with late PE and 269 unaffected controls. The following parameters were recorded: maternal history, mean arterial pressure (MAP), mean uterine artery pulsatility index (UtA-PI), and the concentrations of placental growth factor (PlGF), pregnancy-associated plasma protein A (PAPP-A) and free beta-human chorionic gonadotropin (free ß-hCG). RESULTS: A multivariable stepwise logistic regression analysis indicated that the best screening model for the prediction of early PE is based on a combined analysis of maternal risk factors, UtA-PI and PlGF levels (sensitivity: 91%; specificity: 84%). The best screening model for the prediction of late PE is based on a combined analysis of maternal risk factors, UtA-PI and MAP (sensitivity: 85%; specificity: 83%). The most effective screening model for the prediction of IUGR is based on a combined analysis of maternal risk factors, UtA-PI and PlGF concentrations (sensitivity: 91%; specificity: 83%). CONCLUSIONS: The integrated model of screening established in this study can be a valuable method to identify patients at increased risk of developing pre-eclampsia and related complications. The ability to predict the occurrence of pre-eclampsia in early pregnancy would enable maternal and fetal morbidity to be reduced through the introduction of strict obstetric surveillance as well as planned delivery in a reference center.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Biomarcadores / Artéria Uterina / Retardo do Crescimento Fetal / Pressão Arterial Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Biomarcadores / Artéria Uterina / Retardo do Crescimento Fetal / Pressão Arterial Idioma: En Ano de publicação: 2017 Tipo de documento: Article